1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Global Companion Diagnostics (CDx) Industry 2015 Market Research Report


The Global Companion Diagnostics (CDx) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Companion Diagnostics (CDx) industry.

The report provides a basic overview of the industry including definitions and classifications. The Companion Diagnostics (CDx) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product specification, price, cost, revenue and contact information.

With 134 the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Companion Diagnostics (CDx) Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Basic Information of Companion Diagnostics (CDx)
1.1.1 Definition of Companion Diagnostics (CDx)
1.1.2 Classifications of Companion Diagnostics (CDx)
1.1.3 Applications of Companion Diagnostics (CDx)
1.1.4 Characteristics of Companion Diagnostics (CDx)
1.2 Development Overview of Companion Diagnostics (CDx)
1.3 Enter Barriers Analysis of Companion Diagnostics (CDx)

2 Companion Diagnostics (CDx) International and China Market Analysis
2.1 Companion Diagnostics (CDx) Industry International Market Analysis
2.1.1 Companion Diagnostics (CDx) International Market Development History
2.1.2 Companion Diagnostics (CDx) Competitive Landscape Analysis
2.1.3 Companion Diagnostics (CDx) International Main Countries Development Status
2.1.4 Companion Diagnostics (CDx) International Market Development Trend
2.2 Companion Diagnostics (CDx) Industry China Market Analysis
2.2.1 Companion Diagnostics (CDx) China Market Development History
2.2.2 Companion Diagnostics (CDx) Competitive Landscape Analysis
2.2.3 Companion Diagnostics (CDx) China Main Regions Development Status
2.2.4 Companion Diagnostics (CDx) China Market Development Trend
2.3 Companion Diagnostics (CDx) International and China Market Comparison Analysis

3 Environment Analysis of Companion Diagnostics (CDx)
3.1 International Economy Analysis
3.2 China Economy Analysis
3.3 Policy Analysis of Companion Diagnostics (CDx)
3.4 News Analysis of Companion Diagnostics (CDx)

4 Analysis of Revenue by Classifications
4.1 Global Revenue of Companion Diagnostics (CDx) by Classifications 2010-2015
4.2 Global Revenue Growth Rate of Companion Diagnostics (CDx) by Classifications 2010-2015
4.3 Companion Diagnostics (CDx) Revenue by Classifications

5 Analysis of Revenue by Regions and Applications
5.1 Global Revenue of Companion Diagnostics (CDx) by Regions 2010-2015
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Companion Diagnostics (CDx)
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Companion Diagnostics (CDx)
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Companion Diagnostics (CDx)
5.5 2010-2015 China Revenue and Revenue Growth Rate of Companion Diagnostics (CDx)

6 Analysis of Companion Diagnostics (CDx) Revenue Market Status 2010-2015
6.1 Revenue of Companion Diagnostics (CDx) 2010-2015
6.2 Revenue Market Share Analysis of Companion Diagnostics (CDx) 2010-2015
6.3 Revenue Overview of Companion Diagnostics (CDx) 2010-2015
6.4 Gross Margin of Companion Diagnostics (CDx) 2010-2015

7 Analysis of Companion Diagnostics (CDx) Industry Key Manufacturers
7.1 Roche
7.1.1 Company Profile
7.1.2 Revenue and Gross Margin
7.1.3 Roche SWOT Analysis

7.2 Qiagen
7.2.1 Company Profile
7.2.2 Revenue and Gross Margin
7.2.3 Qiagen SWOT Analysis

7.3 Abbott Molecular
7.3.1 Company Profile
7.3.2 Revenue and Gross Margin
7.3.3 Abbott Molecular SWOT Analysis

7.4 Dako
7.4.1 Company Profile
7.4.2 Revenue and Gross Margin
7.4.3 Dako SWOT Analysis

7.5 Myriad Genetics
7.5.1 Company Profile
7.5.2 Revenue and Gross Margin
7.5.3 Myriad Genetics SWOT Analysis

7.6 BioMerieux
7.6.1 Company Profile
7.6.2 Revenue and Gross Margin
7.6.3 BioMerieux SWOT Analysis

8 Sales Price and Gross Margin Analysis
8.1 Sales Price Analysis of Companion Diagnostics (CDx)
8.2 Gross Margin Analysis of Companion Diagnostics (CDx)

9 Marketing Trader or Distributor Analysis of Companion Diagnostics (CDx)
9.1 Marketing Channels Status of Companion Diagnostics (CDx)
9.2 How Countries Meet Their Needs
9.2.1 USA
9.2.2 China
9.2.3 Japan
9.2.4 Germany

10 Development Trend of Companion Diagnostics (CDx) Industry 2016-2021
10.1 Revenue Overview of Companion Diagnostics (CDx) 2016-2021
10.2 Sales Price Overview of Companion Diagnostics (CDx) 2016-2021

11 Industry Chain Suppliers of Companion Diagnostics (CDx) with Contact Information
11.1 Equipment Suppliers of Companion Diagnostics (CDx) with Contact Information
11.2 Major Suppliers of Companion Diagnostics (CDx) with Contact Information
11.3 Key Consumers of Companion Diagnostics (CDx) with Contact Information
11.4 Supply Chain Relationship Analysis of Companion Diagnostics (CDx)

12 New Project Investment Feasibility Analysis of Companion Diagnostics (CDx)
12.1 New Project SWOT Analysis of Companion Diagnostics (CDx)
12.2 New Project Investment Feasibility Analysis of Companion Diagnostics (CDx)

13 Conclusion of the Global Companion Diagnostics (CDx) Industry 2015 Market Research Report



List of Tables and Figures
Table Classifications of Companion Diagnostics (CDx)
Table Applications of Companion Diagnostics (CDx)
Table Policy of Companion Diagnostics (CDx)
Table Industry News List of Companion Diagnostics (CDx)
Table Global Revenue of Companion Diagnostics (CDx) by Classifications 2010-2015 (M USD)
Table Global Revenue Market Share of Companion Diagnostics (CDx) by Classifications 2010-2015
Figure Global Revenue Market Share of Companion Diagnostics (CDx) by Classifications in 2010
Figure Global Revenue Market Share of Companion Diagnostics (CDx) by Classifications in 2015
Figure Global Revenue Growth Rate of Type One 2010-2015
Figure Global Revenue Growth Rate of Type Two 2010-2015
Figure Global Revenue Growth Rate of Type Three 2010-2015
Table USA Companion Diagnostics (CDx) Revenue by Classifications
Table Europe Companion Diagnostics (CDx) Revenue by Classifications
Table Japan Companion Diagnostics (CDx) Revenue by Classifications
Table China Companion Diagnostics (CDx) Revenue by Classifications
Table Global Revenue of Companion Diagnostics (CDx) by Regions 2010-2015 (M USD)
Table Global Revenue Market Share of Companion Diagnostics (CDx) by Regions 2010-2015
Figure Global Revenue Market Share of Companion Diagnostics (CDx) by Regions in 2010
Figure Global Revenue Market Share of Companion Diagnostics (CDx) by Regions in 2015
Table USA Companion Diagnostics (CDx) Revenue by Applications
Figure USA Companion Diagnostics (CDx) Revenue and Revenue Growth Rate
Table Europe Companion Diagnostics (CDx) Revenue by Applications
Figure Europe Companion Diagnostics (CDx) Revenue and Revenue Growth Rate
Table Japan Companion Diagnostics (CDx) Revenue by Applications
Figure Japan Companion Diagnostics (CDx) Revenue and Revenue Growth Rate
Table China Companion Diagnostics (CDx) Revenue by Applications
Figure China Companion Diagnostics (CDx) Revenue and Revenue Growth Rate
Table Global and China Major Players Companion Diagnostics (CDx) Revenue of 2010-2015 (M USD)
Table Global and China Major Players Companion Diagnostics (CDx) Revenue Market Share of 2010-2015
Table China Major Players Companion Diagnostics (CDx) Revenue of 2010-2015 (M USD)
Table China Major Players Companion Diagnostics (CDx) Revenue Market Share of 2010-2015
Figure Global Revenue Market Share of Major Companion Diagnostics (CDx) Players in 2010
Figure Global Revenue Market Share of Major Companion Diagnostics (CDx) Players in 2015
Figure China Revenue Market Share Major Companion Diagnostics (CDx) Players in 2010
Figure China Revenue Market Share Major Companion Diagnostics (CDx) Players in 2015
Figure Global Revenue and Growth Rate of Companion Diagnostics (CDx) 2010-2015
Figure China Revenue and Growth Rate of Companion Diagnostics (CDx) 2010-2015
Figure 2010-2015 Global and China Companion Diagnostics (CDx) Revenue Comparison
Table Cost of Global Companion Diagnostics (CDx) Major Players 2010-2015 (M USD)
Table Gross of Global Companion Diagnostics (CDx) Major Players 2010-2015 (M USD)
Table Gross Margin of Global Companion Diagnostics (CDx) Major Players 2010-2015
Figure Gross Margin of Global Companion Diagnostics (CDx) Major Players in 2014
Table Company Profile List of Roche
Table Companion Diagnostics (CDx) Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Roche 2010-2015
Figure Companion Diagnostics (CDx) Revenue and Growth Rate of Roche 2010-2015
Table SWOT Analysis of Roche 2010-2015
Table Company Profile List of Qiagen
Table Companion Diagnostics (CDx) Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Qiagen 2010-2015
Figure Companion Diagnostics (CDx) Revenue and Growth Rate of Qiagen 2010-2015
Table SWOT Analysis of Qiagen 2010-2015
Table Company Profile List of Abbott Molecular
Table Companion Diagnostics (CDx) Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Abbott Molecular 2010-2015
Figure Companion Diagnostics (CDx) Revenue and Growth Rate of Abbott Molecular 2010-2015
Table SWOT Analysis of Abbott Molecular 2010-2015
Table Company Profile List of Dako
Table Companion Diagnostics (CDx) Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Dako 2010-2015
Figure Companion Diagnostics (CDx) Revenue and Growth Rate of Dako 2010-2015
Table SWOT Analysis of Dako 2010-2015
Table Company Profile List of Myriad Genetics
Table Companion Diagnostics (CDx) Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of Myriad Genetics 2010-2015
Figure Companion Diagnostics (CDx) Revenue and Growth Rate of Myriad Genetics 2010-2015
Table SWOT Analysis of Myriad Genetics 2010-2015
Table Company Profile List of BioMerieux
Table Companion Diagnostics (CDx) Revenue, Cost, Gross (M USD) Revenue Growth Rate and Gross Margin of BioMerieux 2010-2015
Figure Companion Diagnostics (CDx) Revenue and Growth Rate of BioMerieux 2010-2015
Table SWOT Analysis of BioMerieux 2010-2015
Figure Companion Diagnostics (CDx) Manufactor Profit Model
Figure Marketing Channels Status of Companion Diagnostics (CDx)
Figure Global Revenue and Growth Rate of Companion Diagnostics (CDx) 2016-2021
Figure China Revenue and Growth Rate of Companion Diagnostics (CDx) 2016-2021
Figure Global and China Companion Diagnostics (CDx) Revenue Comparison 2016-2021
Table Equipment Suppliers of Companion Diagnostics (CDx) with Contact Information
Table Major Suppliers of Companion Diagnostics (CDx) with Contact Information
Table Key Consumers of Companion Diagnostics (CDx) with Contact Information
Figure Supply Chain Relationship Analysis of Companion Diagnostics (CDx)
Table New Project SWOT Analysis of Companion Diagnostics (CDx)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.